Oxibendazole
未知生产厂商
Oxibendazole is a polymerase inhibitor in phase III trials for the treatment of helminth intestinal infections.
Oxibendazole is a polymerase inhibitor in phase III trials for the treatment of helminth intestinal infections.
Oxibendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores. Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP), which is the energy required for the survival of the helminth. Due to diminished energy production, the parasite is immobilized and eventually dies.
主要用于驱除蛔虫、钩虫和鞭虫。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
